Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.
about
The Cryptococcus neoformans capsule: a sword and a shield.A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic OutcomeBiochemical characterization of Paracoccidioides brasiliensis α-1,3-glucanase Agn1p, and its functionality by heterologous Expression in Schizosaccharomyces pombeBinding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.Fission yeast Ags1 confers the essential septum strength needed for safe gradual cell abscissionA beta-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases.Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule.Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactionsPbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.The Neurospora crassa CPS-1 polysaccharide synthase functions in cell wall biosynthesisNeurospora crassa 1,3-α-glucan synthase, AGS-1, is required for cell wall biosynthesis during macroconidia development.Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the hostIdentification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformansPleiotropic effects of deubiquitinating enzyme Ubp5 on growth and pathogenesis of Cryptococcus neoformans.Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.Functional analysis of the α-1,3-glucan synthase genes agsA and agsB in Aspergillus nidulans: agsB is the major α-1,3-glucan synthase in this fungus.A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.The F-Box protein Fbp1 regulates sexual reproduction and virulence in Cryptococcus neoformans.Emerging themes in cryptococcal capsule synthesisChronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformansDiscovery and Characterization of a Peptoid with Antifungal Activity against Cryptococcus neoformans.Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown propertiesMolecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses.Deletion of the α-(1,3)-glucan synthase genes induces a restructuring of the conidial cell wall responsible for the avirulence of Aspergillus fumigatus.The capsule of the fungal pathogen Cryptococcus neoformans.Biochemical characterization of potential virulence markers in the human fungal pathogen Pseudallescheria boydii.Caspofungin: when and how? The microbiologist's view.New β-glucan inhibitors as antifungal drugs.Beta-glucan: an ideal immunostimulant in aquaculture (a review).Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformansCryptococcal therapies and drug targets: the old, the new and the promising.Biological roles of glycans.Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal SusceptibilitySurfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival.
P2860
Q24619875-EB10676C-015C-43B2-984D-A08947E5C64BQ27319842-C576B31B-5458-4CCF-A414-AAABC92E0DCFQ28534317-0449FC50-98BC-476F-8DF6-AEB32514F282Q30481655-287DA28F-3EC8-45E3-84A7-F6FA35F80406Q30528923-52DE47B0-0BDB-458C-B0F7-6A5C3D0D8D08Q31109146-8822E61F-320F-4F46-837F-207A978EB121Q33533286-59D271DD-F3EB-4C84-955C-A845B1C21861Q33601505-2A4477B0-DF8F-42A1-8AD2-7BC853F2410FQ33766799-FE4EAA93-8206-4FBD-BEC4-B624D232069CQ33790656-923928A7-103E-4027-A637-D7B6DC8049D9Q33894565-F2ADF791-BFDA-4CE1-844A-AE0D1A150FB3Q33969112-CCC40126-263A-40E1-8300-95E58B811AE4Q33980452-3CF2B7B5-537F-4C92-9EAC-8507AC358507Q34055174-B304989B-66F9-4C48-9783-7F5E3DFC1FF0Q34229854-92B7DB0A-6A2C-4846-BC99-0DFAA873A7F2Q34265597-C44A4D9F-8663-4AFE-8F1C-490729328654Q34311864-4311DC25-2F8F-43F4-A37D-41681C1C1B62Q34561087-B0FFE9F0-E28E-41B0-90A8-1BE24B13E558Q34568398-1BC0C61F-CEFD-483A-BB8F-9D810F3F7FB8Q34907746-230EEE06-D1B9-4236-85F7-10A557BB66D8Q34961105-D862E088-7B0C-4092-BE12-59FBFC0BF920Q35080879-550853D7-E2B0-4281-846B-541314F1A8EFQ35291602-7B15CB48-6A8F-428D-81FA-1D7C9682AEE8Q35598044-A606CB4C-02A3-4D51-8AAC-A1527CFE4B5EQ36229042-D87833B4-3A91-4DB4-89C7-62F23B257DE6Q36244332-2E7DCAA1-2D08-4285-B159-4295B10D9E54Q36456615-15B79231-1100-4525-B2D7-517D76EF5470Q36472903-1BB38C25-DD36-4215-AE31-C4DC0647566FQ36551864-1E370982-8226-45F6-ADCC-A52E535B3842Q37308743-4AF6038D-737F-4D79-94F6-729B63A861B5Q37337879-7C43E8B0-0FFE-4F64-A3E5-F46D04178EFCQ37398912-89116E6A-DA68-454C-9521-0287089B98F2Q37888750-D4FC37CF-0958-4BBD-9A5D-29F6492C0DF5Q37905055-A8A47DBC-8905-4C98-8E37-80E1C8080423Q38042414-02B8003C-9737-4419-836A-B4A313BA574CQ38259355-7237AEE7-0D3A-49F2-89E1-8ADCDD7DB849Q38779568-DBEA5298-1C74-4234-B742-FA1F15DC5465Q38936714-603391EC-976A-4321-AEE9-B805715FA6D5Q39061501-020DCFD0-5246-47BB-B072-16E0BA611DBCQ39849808-6A853DAB-5CDF-4014-B66C-B09092B1DD8C
P2860
Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@ast
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@en
type
label
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@ast
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@en
prefLabel
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@ast
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@en
P2093
P2860
P921
P1476
Loss of cell wall alpha(1-3) g ...... m ultrastructure to virulence.
@en
P2093
Aki Yoneda
Amy J Reese
Anne Beauvais
Cara L Griffith
Colleen Skau
Eleftherios Mylonakis
Indrani Bose
Jean-Paul Latge
Julia A Breger
P2860
P304
P356
10.1111/J.1365-2958.2006.05551.X
P407
P577
2007-03-01T00:00:00Z